1. Current perspectives in dissolution testing of conventional and novel dosage forms
2. U.S. Department of Health and Human Services FDA (US FDA). Guidance for Industry: Immediate Release Solid Oral Dosage Forms Scale-Up and Post-Approval Changes: Chemistry, Manufacturing, and Controls,in vitroDissolution Testing, andin vivoBioequivalence Documentation. U.S. Department of Health and Human Services FDA: Silver Spring, MD, USA, 1995.
3. U.S. Department of Health and Human Services FDA (US FDA). Guidance for Industry SUPAC-MR: Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation. U.S. Department of Health and Human Services FDA: Silver Spring, MD, USA, 1997.
4. U.S. Department of Health and Human Services FDA (US FDA). Bioavailability and Bioequivalence Studies for Orally Administered Drug Products- General Considerations. U.S. Department of Health and Human Services FDA: Silver Spring, MD, USA, 2003.